MONIQUE PRINCE: Open Payments
NPI 1528349297 · EUSTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,406 in 55 payments from 23 companies in 2025. Trend: 2023 $1,206 · 2024 $1,880 · 2025 $3,406
Food & beverage: $3,406
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $960 |
| Novo Nordisk Inc | 8 | $467 |
| Amgen Inc. | 7 | $404 |
| Gilead Sciences, Inc. | 2 | $259 |
| ABIOMED | 2 | $229 |
| Axsome Therapeutics, Inc. | 2 | $147 |
| Medtronic, Inc. | 1 | $146 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Eisai Inc. | 1 | $112 |
| Teva Pharmaceuticals USA, Inc. | 1 | $100 |
Products named: BREZTRI, OTEZLA, AIRSUPRA, Ozempic, FARXIGA, Auvelity, SYMPLICITY G3, Wegovy.
Industry payments across FL — which companies pay providers there.
